Primary Record
Faridoxorubicin
- In stock
- 4,443 g
- Purity
- 98.6 %
- CAS
- 1841402-73-0
Compound Identifiers & Properties
- CAS
- 1841402-73-0
- PubChem CID
- 118584251
- SMILES
- C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)NC(=O)[C@@H]6CCCN6C(=O)[C@@H](C)NC(=O)C7=CC=NC=C7)O
- Canonical SMILES
- COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H](C)NC(=O)c2ccncc2)[C@H](O)[C@H](C)O1
Names & Synonyms
- Faridoxorubicin
- 7XPB9B6MUA
- faridoxorubicin [INN]
- UNII-7XPB9B6MUA
- AVA6000
- RefChem:1077361
- AVA-6000
- SCHEMBL17345374
- AVA 6000
- AVA-6000 (fap-activated doxorubicin prodrug)
- FAP-activated Doxorubicin Prodrug AVA6000
- 1841402-73-0
- Fibroblast Activation Protein Alpha-activated Doxorubicin Prodrug AVA6000
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[[N-(4-pyridinylcarbonyl)-D-alanyl-L-prolyl]amino]-alpha-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)-